Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says

9:37am PDT - May 18th, 2020    moderna - Business Insider

• Goldman Sachs lifted its price target for Moderna stock to $105 from $63 on Monday after first trials for its coronavirus drug showed "encouraging" results.
• Moderna announced Monday that all 45 volunteers in the trial produced antibodies to …